Global  

Covid vaccine shows promising early results in China

IndiaTimes Saturday, 23 May 2020
The trial is the first step in testing the vaccine and was intended mainly to verify its safety. Proof of its effectiveness will require trials in thousands, perhaps hundreds of thousands, more people.
0
shares
ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

Equity indices up on vaccine hopes, banking and financial stocks gain [Video]

Equity indices up on vaccine hopes, banking and financial stocks gain

Equity benchmark indices were up by nearly one per cent during early hours on July 02 tracking gains in Asian peers as investors hoped of a vaccine for COVID-19. At 10:15 am, the BSE SandP Sensex was..

Credit: ANI     Duration: 01:50Published
China Approves COVID-19 Vaccine For Military Use [Video]

China Approves COVID-19 Vaccine For Military Use

The Chinese government has announced the approval of an experimental Covid-19 vaccine. According to CNN, the new vaccine is only approved for use in the country's military personnel. The vaccine,..

Credit: Wochit     Duration: 00:30Published
Covid update: Bihar wedding hotspot; new virus in China; EU bars Indians [Video]

Covid update: Bihar wedding hotspot; new virus in China; EU bars Indians

From researchers warning of a new virus in China with pandemic potential, to travellers from India, among others, being barred from entry into European Union countries - here are the top ten news..

Credit: HT Digital Content     Duration: 04:15Published

Related news from verified sources

Coronavirus Vaccine Shows Promising Early Results in China

A trial with 108 participants suggests the vaccine is safe and may be moderately effective. But experts noted that the approach has failed in the past.
NYTimes.com

Potential COVID-19 vaccine shows promising early results

A Phase 1 trial of a prospective COVID-19 vaccine that will soon be tested on Canadians has found it to be safe and also prompted an immune response, but...
CBC.ca

China gets 'promising' early results from COVID-19 vaccine trial

Within two weeks of getting the vaccine, some developed so-called neutralizing antibodies, which can kill SARS-CoV-2, the virus that causes COVID-19.
USATODAY.com


Tweets about this